PF-06252616
PF-06252616 Uses, Dosage, Side Effects, Food Interaction and all others data.
PF-06252616 is under investigation in clinical trial NCT01616277 (A Phase 1 Study To Evaluate The Safety And Tolerability Of PF-06252616 In Healthy Subjects).
| Trade Name | PF-06252616 |
| Generic | Domagrozumab |
| Domagrozumab Other Names | Domagrozumab, PF-06252616 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here PF-06252616
